A Phase II Trial of Guadecitabine plus Atezolizumab in Metastatic Urothelial Carcinoma Progressing after Initial Immune Checkpoint Inhibitor Therapy.
Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Jang, H Josh HJ; Hostetter, Galen G; MacFarlane, Alexander W AW; Madaj, Zachary Z; Ross, Eric A EA; Hinoue, Toshinori T; Kulchycki, Justin R JR; Burgos, Ryan S RS; Tafseer, Mahvish M; Alpaugh, R Katherine RK; Schwebel, Candice L CL; Kokate, Rutika R; Geynisman, Daniel M DM; Zibelman, Matthew R MR; Ghatalia, Pooja P; Nichols, Peter W PW; Chung, Woonbok W; Madzo, Jozef J; Hahn, Noah M NM; Quinn, David I DI; Issa, Jean-Pierre J JJ; Topper, Michael J MJ; Baylin, Stephen B SB; Shen, Hui H; Campbell, Kerry S KS; Jones, Peter A PA; Plimack, Elizabeth R ER
Integration of genomics and histology revises diagnosis and enables effective therapy of refractory cancer of unknown primary with PDL1 amplification.
Cold Spring Harbor Molecular Case Studies
Gröschel, Stefan S; Bommer, Martin M; Hutter, Barbara B; Budczies, Jan J; Bonekamp, David D; Heining, Christoph C; Horak, Peter P; Fröhlich, Martina M; Uhrig, Sebastian S; Hübschmann, Daniel D; Geörg, Christina C; Richter, Daniela D; Pfarr, Nicole N; Pfütze, Katrin K; Wolf, Stephan S; Schirmacher, Peter P; Jäger, Dirk D; von Kalle, Christof C; Brors, Benedikt B; Glimm, Hanno H; Weichert, Wilko W; Stenzinger, Albrecht A; Fröhling, Stefan S